Information
-
Trademark
-
85807308
-
International Classifications
-
Filing Date
December 20, 2012
12 years ago
-
Transaction Date
November 07, 2013
11 years ago
-
Status Date
November 07, 2013
11 years ago
-
Location Date
November 07, 2013
11 years ago
-
Status Code
602
-
Current Location
TMEG LAW OFFICE 102 - EXAMINING ATTORNEY ASSIGNED
Employee Name
KUYKENDALL, LINDSEY
-
Attorney Docket Number
60895-342375
Attorney Name
Mark Harrison
Law Office Assigned Location Code
L20
-
Owners
Mark Drawing Code
4000
Mark Identification
SYNTHETYX
Case File Statements
- GS0011: Human cells and isogenic cell lines for scientific, laboratory or medical research; genomic reference control samples for medical laboratory use; Molecular biology research tools, in the nature of biological and biochemical reagents, specifically, genomic DNA; DNA repair enzymes
- GS0051: Biological and chemical reagents, including, genomic DNA, cell cultures and mutant and normal isogenic human cell line pairs, for research use; protein cell lysates, genomic DNA preparations and FFPE engineered tumor mimics for diagnostic use
- GS0421: Custom cell-line engineering services; gene-editing services; DNA modeling services; gene engineering services; bio-technology, pharmaceutical and scientific testing, research, development, advice, consultancy and information services; biological research; biology and chemistry services; pharmaceutical research services; drug discovery services; research and development services for lead identification and validation; research and development services for target identification and validation; identification of patient-relevant drug targets; optimisation of drug candidates for clinical development; diagnostic services; medicinal and synthetic chemistry services; research and development services in the creation of libraries or collections of biologicals including cells and cell lines, chemicals and compounds; creating libraries or collections of normal and mutated genes; research and development services relating to targeting therapies to individuals; establishing patient genotypes; research and development services relating to combining therapies for individuals; research and development relating to reagents; disease modelling; design of clinical trials; research and development in re-positioning existing drugs from other therapeutic indications
- PM0000: SYNTHETICS
Case File Event Statements
-
11/7/2013 - 11 years ago
8 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Type: MAB2
-
11/7/2013 - 11 years ago
7 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Type: ABN2
-
4/11/2013 - 11 years ago
6 - NON-FINAL ACTION MAILED
Type: CNRT
-
4/10/2013 - 11 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
4/8/2013 - 11 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
1/9/2013 - 11 years ago
3 - NOTICE OF PSEUDO MARK MAILED
Type: MPMK
-
1/8/2013 - 11 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
12/24/2012 - 12 years ago
1 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP